CP Kelco Seeks Strategic Buyer for Carrageenan Plant in Cebu, Philippines
ATLANTA, May 31, 2017 (GLOBE NEWSWIRE) -- CP Kelco currently produces carrageenan products at manufacturing plants in Lille Skensved, Denmark, and Sibonga, Cebu, Philippines. Based on CP Kelco's strategy and business objectives, a decision has been made to seek a strategic buyer for the Cebu site.
CP Kelco is not exiting the carrageenan business. Utilizing our deep applications expertise and technology, the company remains committed to providing the global market with high-quality carrageenan products, now and in the future.
About CP Kelco
Headquartered in Atlanta, Georgia, USA, and part of J.M. Huber Corporation, CP Kelco is a leading producer of specialty hydrocolloids with offices and facilities across the globe. Featuring an extensive range of hydrocolloid solutions and serving over 100 countries, CP Kelco leverages its capabilities to bring concepts and ideas to real-world products in a broad range of applications. The company's specialty ingredients touch a wide variety of consumer and household products and industrial applications, tailored to meet the needs of regional consumers. Key product lines are Gellan Gum , Pectin , Xanthan Gum , Cellulose Gum , Carrageenan , Diutan Gum and Microparticulated Whey Protein Concentrate , as well as other unique biopolymers. Visit www.cpkelco.com for more information.
Director, Global Communications
Office: +1 678 247 7149
Mobile: +1 770 743 0564
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
VITEC20.3.2018 17:01 | pressemeddelelse
VITEC Adds Powerful New Video Wall and DRM Functionality to EZ TV IPTV and Digital Signage Platform
Millennial Esports Corp.20.3.2018 14:00 | pressemeddelelse
Millennial Esports' Eden Games Amongst First Studios to Integrate Amazon GameOn
Merus N.V.20.3.2018 12:01 | pressemeddelelse
Merus and the Vall d'Hebron Institute of Oncology Announce Research Collaboration to Develop Innovative Bispecific Antibodies for Therapeutic Applications in the Treatment of Cancer
Auth020.3.2018 10:02 | pressemeddelelse
Auth0 Announces Key Distribution Partnership with AppXite
McDonald's Corporation20.3.2018 09:05 | pressemeddelelse
McDonald's Becomes the First Restaurant Company to Set Approved Science Based Target to Reduce Greenhouse Gas Emissions
Elemica19.3.2018 13:11 | pressemeddelelse
New Elemica Trace Solution Delivers Shipment Risk Analysis for Digital Transformation
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum